The Risk of Recurrence in Grade 2 Pancreatic Neuroendocrine Tumors

HPB - United Kingdom
doi 10.1016/j.hpb.2018.06.2088
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Risk Factors for Pancreatic Neuroendocrine Tumors

Pancreas
Internal MedicineEndocrinologyHepatologyMetabolismDiabetes
2014English

Pancreatic Neuroendocrine Tumors

Revista Espanola de Enfermedades Digestivas
MedicineGastroenterology
2017English

A Combined Nomogram Model to Preoperatively Predict Histologic Grade in Pancreatic Neuroendocrine Tumors

Clinical Cancer Research
Cancer ResearchOncology
2018English

Molecular Pathogenesis of Pancreatic Neuroendocrine Tumors

Cancers
Cancer ResearchOncology
2010English

Promising Developments for Pancreatic Neuroendocrine Tumors

Cancer Discovery
Oncology
2011English

Sunitinib in Pancreatic Neuroendocrine Tumors. Clinical Case

Medical Council
2019English

State-Of-The-Art Imaging of Pancreatic Neuroendocrine Tumors

Surgical Oncology Clinics of North America
SurgeryOncology
2016English

Small Pancreatic Neuroendocrine Tumors: Resect or Enucleate?

HPB
HepatologyGastroenterology
2019English

Differences Between Grades G1 and G2 Hypovascular Pancreatic Neuroendocrine Tumors and Pancreatic Neuroendocrine Carcinoma

Radiology
Nuclear MedicineRadiologyImaging
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy